Stryker (SYK)
(Delayed Data from NYSE)
$356.15 USD
-2.36 (-0.66%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $356.17 +0.02 (0.01%) 7:38 PM ET
3-Hold of 5 3
C Value D Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Stryker Corporation [SYK]
Reports for Purchase
Showing records 461 - 476 ( 476 total )
Company: Stryker Corporation
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Stryker Corporation
Industry: Medical - Products
If it?s not Neuromodulation, then its Neurovascular...SYK enters into a completely new area
Provider: RODMAN & RENSHAW, CO.
Company: Stryker Corporation
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Stryker Corporation
Industry: Medical - Products
Company: Stryker Corporation
Industry: Medical - Products
Stronger than expected MedSurg sales results in good Q3 showing; We still remain on the
Provider: RODMAN & RENSHAW, CO.
Company: Stryker Corporation
Industry: Medical - Products
Benefits of acquiring BSX Neuromodulation Unit at 5x sales are not obvious to us
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Stryker Corporation
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Stryker Corporation
Industry: Medical - Products
Company: Stryker Corporation
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Stryker Corporation
Industry: Medical - Products
Company: Stryker Corporation
Industry: Medical - Products
Company: Stryker Corporation
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Stryker Corporation
Industry: Medical - Products
We are initiating coverage with a Market Perform rating.
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Stryker Corporation
Industry: Medical - Products
Company: Stryker Corporation
Industry: Medical - Products
Company: Stryker Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: TITUS C